Vericel Net Receivables from 2010 to 2026

VCEL Stock  USD 36.94  0.96  2.67%   
Vericel Corp Net Receivables yearly trend continues to be quite stable with very little volatility. Net Receivables may rise above about 74.1 M this year. From the period between 2010 and 2026, Vericel Corp, Net Receivables regression line of its data series had standard deviation of  25,612,729 and standard deviation of  25,612,729. View All Fundamentals
 
Net Receivables  
First Reported
1996-09-30
Previous Quarter
64.3 M
Current Value
60.4 M
Quarterly Volatility
17.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Vericel Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vericel Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.6 M, Interest Expense of 741.4 K or Total Revenue of 286.4 M, as well as many indicators such as Price To Sales Ratio of 9.67, Dividend Yield of 0.0 or PTB Ratio of 4.46. Vericel financial statements analysis is a perfect complement when working with Vericel Corp Valuation or Volatility modules.
  
Build AI portfolio with Vericel Stock
Check out the analysis of Vericel Corp Correlation against competitors.
Historical Net Receivables data for Vericel Corp serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Vericel Corp Ord represents a compelling investment opportunity.

Latest Vericel Corp's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Vericel Corp Ord over the last few years. It is Vericel Corp's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vericel Corp's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Vericel Net Receivables Regression Statistics

Arithmetic Mean29,008,386
Geometric Mean5,570,228
Coefficient Of Variation88.29
Mean Deviation21,529,821
Median23,454,000
Standard Deviation25,612,729
Sample Variance656T
Range74.1M
R-Value0.98
Mean Square Error28T
R-Squared0.96
Slope4,969,550
Total Sum of Squares10496.2T

Vericel Net Receivables History

202674.1 M
202570.6 M
202461.4 M
202358.4 M
202246.5 M
202137.4 M
202034.5 M

About Vericel Corp Financial Statements

Vericel Corp investors utilize fundamental indicators, such as Net Receivables, to predict how Vericel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables70.6 M74.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out the analysis of Vericel Corp Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Vericel Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
0.476
Earnings Share
0.26
Revenue Per Share
5.168
Quarterly Revenue Growth
0.166
Return On Assets
0.0105
Investors evaluate Vericel Corp Ord using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Vericel Corp's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Vericel Corp's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Vericel Corp's market price signifies the transaction level at which participants voluntarily complete trades.